Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biographical Feature: Peter H. Gilligan, Ph.D., D(ABMM), F(AAM).

Literature DB >> 30541940

Biographical Feature: Peter H. Gilligan, Ph.D., D(ABMM), F(AAM).

Erik Munson¹.

Abstract

Mesh：

Year: 2019 PMID： 30541940 PMCID： PMC6355517 DOI： 10.1128/JCM.01872-18

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

× No keyword cloud information.

27 in total

Review 1. Therapeutic challenges posed by bacterial bioterrorism threats.

Authors: Peter H Gilligan
Journal: Curr Opin Microbiol Date: 2002-10 Impact factor: 7.934

2. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors: J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal: Clin Infect Dis Date: 2018-08-31 Impact factor: 9.079

3. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.

Authors: P H Gilligan; T P Walden; W F Kelly; K J Wait; J A Kraft; D H Willis
Journal: Arch Pathol Lab Med Date: 1993-05 Impact factor: 5.534

4. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type.

Authors: R M Aris; J C Routh; J J LiPuma; D G Heath; P H Gilligan
Journal: Am J Respir Crit Care Med Date: 2001-12-01 Impact factor: 21.405

5. Nutritional requirements for synthesis of heat-labile enterotoxin by enterotoxigenic strains of Escherichia coli.

Authors: P H Gilligan; D C Robertson
Journal: Infect Immun Date: 1979-01 Impact factor: 3.441

6. Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center.

Authors: Marcus P Kennedy; Raymond D Coakley; Scott H Donaldson; Robert M Aris; Kathy Hohneker; Joel P Wedd; Michael R Knowles; Peter H Gilligan; James R Yankaskas
Journal: J Cyst Fibros Date: 2006-11-29 Impact factor: 5.482

7. Clostridium difficile cytotoxin in a pediatric population.

Authors: C M Thompson; P H Gilligan; M C Fisher; S S Long
Journal: Am J Dis Child Date: 1983-03

8. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.

Authors: Katherine Schultz; Emily Sickbert-Bennett; Ashley Marx; David J Weber; Lauren M DiBiase; Stacy Campbell-Bright; Lauren E Bode; Mike Baker; Tom Belhorn; Mark Buchanan; Sherie Goldbach; Jacci Harden; Emily Hoke; Beth Huenniger; Jonathan J Juliano; Michael Langston; Heather Ritchie; William A Rutala; Jason Smith; Shelley Summerlin-Long; Lisa Teal; Peter Gilligan
Journal: J Clin Microbiol Date: 2018-08-27 Impact factor: 5.948

9. Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?

Authors: Peter H Gilligan
Journal: J Clin Microbiol Date: 2008-02-06 Impact factor: 5.948

10. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.

Authors: S Steinbach; L Sun; R Z Jiang; P Flume; P Gilligan; T M Egan; R Goldstein
Journal: N Engl J Med Date: 1994-10-13 Impact factor: 91.245

4 in total